Andrew Payne

Andrew Payne is the Co-Founder and CEO of E11 Bio, with a background in in situ genome sequencing, super-resolution microscopy, and spatially resolved genomics, transcriptomics, proteomics, and connectomics. Prior to that, Andrew was a Graduate Student at Massachusetts Institute of Technology, where Andrew also worked as a Visiting Student in the Synthetic Neurobiology Group. Andrew has experience as an Undergraduate Research Student at the Wyss Institute for Biologically Inspired Engineering and as a Research Associate at Halcyon Molecular. Payne holds a PhD and MS from Massachusetts Institute of Technology, and a BASc in Engineering Science from the University of Toronto.